Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CoQ10: Congestive heart failure - Nutraceuticals World
Research

CoQ10: Congestive heart failure

Nutraceutical: CoQ10

Indication: Congestive heart failure

Source: Am J Clin Nutr Dec. 5, 2012; doi:10.3945 (Epub ahead of print)

Research: This meta-analysis evaluated the impact of CoQ10 supplementation on the ejection fraction (EF) and New York Heart Association (NYHA) functional classification in patients with congestive heart failure (CHF). A systematic review of literature was conducted. Studies included were randomized controlled trials of CoQ10 supplementation that reported the EF or NYHA functional class as a primary outcome.

Results: Supplementation with CoQ10 resulted in a pooled mean net change of 3.67% (95% CI: 1.60%, 5.74%) in the EF and −0.30 (95% CI: −0.66, 0.06) in the NYHA functional class. Subgroup analyses showed significant improvement in EF for crossover trials, trials with treatment duration ≤12 week in length, studies published before 1994 and studies with a dose ≤100 mg CoQ10/day, and in patients with less severe CHF. Researchers concluded that pooled analyses of available randomized controlled trials suggest CoQ10 may improve the EF in patients with CHF.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters